SCHEMBL9968903

SCHEMBL9968903

COC(=O)c1ccc(/C(N)=N/O)cc1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.56
GAA P10253 4/20 0.53
RAB9A P51151 5/20 0.49
KDM4E B2RXH2 3/20 0.49
KMT2A Q03164 3/20 0.49
CASP3 P42574 1/20 0.49
SENP8 Q96LD8 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
MAPT P10636 5/20 0.49
NPC1 O15118 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
ALDH1A1 P00352 2/20 0.48
HPGD P15428 2/20 0.48
LMNA P02545 2/20 0.48
POLB P06746 2/20 0.48
GLA P06280 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
ATM Q13315 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2773601 1.00 RECQL (0.56) RECQLGAARAB9AKDM4EKMT2A
SCHEMBL2773603 1.00 RECQL (0.56) RECQLGAARAB9AKDM4EKMT2A
SCHEMBL2773580 0.88 GAA (0.60) RECQLGAARAB9AKDM4EKMT2A
SCHEMBL28413725 0.88 RECQL (0.60) RECQLGAARAB9AKDM4EKMT2A
SCHEMBL25707071 0.88 RECQL (0.60) RECQLGAARAB9AKDM4EKMT2A
SCHEMBL2773585 0.88 GAA (0.60) RECQLGAARAB9AKDM4EKMT2A
SCHEMBL30745101 0.88 RECQL (0.60) RECQLGAARAB9AKDM4EKMT2A
SCHEMBL9968902 0.88 GAA (0.60) RECQLGAARAB9AKDM4EKMT2A
SCHEMBL20963465 0.88 RECQL (0.60) RECQLGAARAB9AKDM4EKMT2A
SCHEMBL16935790 0.86 RECQL (0.58) RECQLGAARAB9AKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8202865-B2 Oxadiazole derivatives MERCK SERONO SA (CH) 2012-06-19 US disclosed
US-8202865-B2 Oxadiazole derivatives MERCK SERONO SA (CH) 2012-06-19 US disclosed
US-20100240658-A1 Oxadiazole Derivatives MERCK SERONO SA (CH) 2010-09-23 US disclosed
US-20100240658-A1 Oxadiazole Derivatives MERCK SERONO SA (CH) 2010-09-23 US disclosed
WO-2009043889-A2 OXADIAZOLE DERIVATIVES MERCK SERONO S.A. (CH) 2009-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240658-A1 Oxadiazole Derivatives OXA1L, RO60, NQO2 RECQL 4/4885GAA 3886/4885RAB9A 2090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.